AJELLO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 608
EU - Europa 463
AS - Asia 156
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.229
Nazione #
US - Stati Uniti d'America 601
IE - Irlanda 141
SE - Svezia 121
CN - Cina 101
UA - Ucraina 65
DE - Germania 53
SG - Singapore 45
GB - Regno Unito 34
FI - Finlandia 22
BE - Belgio 15
IN - India 8
CA - Canada 7
IT - Italia 7
RU - Federazione Russa 3
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
TR - Turchia 1
Totale 1.229
Città #
Dublin 141
Jacksonville 137
Chandler 113
Nyköping 74
Beijing 59
Ann Arbor 54
Ashburn 39
Singapore 33
Lancaster 22
Cambridge 21
Medford 21
Princeton 21
Woodbridge 20
Des Moines 16
Boardman 15
Brussels 15
Munich 13
Los Angeles 11
Pune 8
Dearborn 7
Jinan 6
Auburn Hills 5
Ottawa 5
Haikou 4
Mountain View 4
San Mateo 4
Changsha 3
Guangzhou 3
Hangzhou 3
Salerno 3
Bari 2
Kunming 2
Nanjing 2
Saint Petersburg 2
Taiyuan 2
Taizhou 2
Washington 2
Wilmington 2
Ardabil 1
Boston 1
Chicago 1
Chongqing 1
Fort Payne 1
Fuzhou 1
Ganzhou 1
Granby 1
Hefei 1
Helsinki 1
Lanzhou 1
Milan 1
Nanchang 1
Norwalk 1
Phoenix 1
Prague 1
Saint Louis 1
Seattle 1
Shanghai 1
Tianjin 1
Toronto 1
Zhengzhou 1
Totale 918
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 89
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 83
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 79
Infezione da virus dell'epatite C e tossicodipendenza 76
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 71
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 66
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 58
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 58
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 58
Ten year follow-up of patients with chronic hepatitis C treated with interferon 56
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 54
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 53
Tamoxifen in the treatment of Hepatocellular Carcinoma: 5-year results of the CLIP-1 multicentre randomized controlled trial 52
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards 52
La steatoepatite non alcolica, fattori di rischio e aspetti umorali 51
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 51
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 51
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 50
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 46
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 42
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 41
Totale 1.237
Categoria #
all - tutte 4.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 0 12 25 22 2 50 33 1
2020/2021149 21 3 37 7 3 22 1 20 3 14 10 8
2021/2022137 1 27 4 5 6 2 4 5 3 18 19 43
2022/2023427 27 42 32 23 44 42 1 35 165 2 11 3
2023/202489 6 14 5 10 10 28 0 10 0 1 0 5
2024/202574 2 10 7 47 0 8 0 0 0 0 0 0
Totale 1.237